Marksans Pharma Adjusts Evaluation Score Amid Mixed Technical Indicators and Strong Management Efficiency
Marksans Pharma has recently adjusted its evaluation score, reflecting a change in technical trends. The stock exhibits mixed performance indicators, with bullish momentum on a weekly basis and a mildly bearish outlook monthly. The company continues to show strong management efficiency and consistent returns over the past three years.
Marksans Pharma, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a sideways pattern to a mildly bullish outlook. The stock's performance indicators reveal a mixed technical landscape. The MACD shows bullish momentum on a weekly basis, while the monthly perspective leans mildly bearish. The Relative Strength Index (RSI) indicates no significant signals for both weekly and monthly periods. Bollinger Bands present a bullish stance in both timeframes, suggesting potential upward movement. Moving averages, however, indicate a mildly bearish trend on a daily basis, while the KST shows a mildly bullish outlook weekly and mildly bearish monthly.
Marksans Pharma's recent stock price is 263.70, up from a previous close of 250.20, with a 52-week high of 358.50 and a low of 154.45. The company has demonstrated consistent returns over the past three years, outperforming the BSE 500 in each of the last three annual periods. Despite a flat financial performance in the latest quarter, the company maintains a high return on equity (ROE) of 17.66% and a low debt-to-equity ratio, indicating strong management efficiency.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
